Clough Capital Partners’s Roivant Sciences ROIV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $387K | Hold |
34,300
| – | – | 0.04% | 112 |
|
|
2025
Q1 | $346K | Hold |
34,300
| – | – | 0.04% | 102 |
|
|
2024
Q4 | $406K | Sell |
34,300
-53,907
| -61% | -$638K | 0.05% | 111 |
|
|
2024
Q3 | $1.02M | Sell |
88,207
-288,730
| -77% | -$3.33M | 0.1% | 100 |
|
|
2024
Q2 | $3.98M | Sell |
376,937
-291,618
| -44% | -$3.08M | 0.44% | 57 |
|
|
2024
Q1 | $7.05M | Sell |
668,555
-10,105
| -1% | -$107K | 0.77% | 47 |
|
|
2023
Q4 | $7.62M | Sell |
678,660
-44,140
| -6% | -$496K | 0.84% | 40 |
|
|
2023
Q3 | $8.44M | Buy |
722,800
+215,300
| +42% | +$2.51M | 0.91% | 41 |
|
|
2023
Q2 | $5.12M | Buy |
+507,500
| New | +$5.12M | 0.51% | 62 |
|